We were paying for all the innovation in this country, and the rest of the world was free riding on it."Horse shit
Eat your heart out as Germany goes into the toilet.
you are a 70+ guy who had trouble taking a dump i won´t take offence to your childish comment
The global biotech and pharmaceutical landscape in 2024 continued to attract significant investment, with our BiopharmIQ system capturing 651 early and late-stage funding events securing over $1M. The United States remained the dominant force, with 361 funding events reaching this funding milestone, reinforcing its leadership in biotech innovation. The United Kingdom (55), China (46), and Switzerland (34) also continued to be key investment hubs. Emerging biotech and pharma regions such as India, South Korea, and Israel continue to attract venture capital and private funding (See FIG. 1).